Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Blood Advances|February 27, 2025
Integrative cytogenetic and molecular studies unmask "chromosomal mimicry" in hematologic malignanciesMelissa Zhao, Scott Ryall, Samuel J Brody, et al.Neuro-Oncology|April 4, 2020
Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomasKohei Fukuoka, Yasin Mamatjan, Ruth Tatevossian, et al.Nature Cancer|May 7, 2025
A population-based analysis of the molecular landscape of glioma in adolescents and young adults reveals insights into gliomagenesisJulie Bennett, Adrian B Levine, Liana Nobre, et al.Cancer Cell|April 15, 2020
Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade GliomasScott Ryall, Michal Zapotocky, Kohei Fukuoka, et al.Neuro-Oncology|November 9, 2025
A Systematic Study of Molecular Diagnosis, Treatment and Prognosis in Infant-Type Hemispheric Glioma): An Individual Patient Data Meta-analysis of 164 patientsLara Chavaz, Aditi Bagchi, Sandeep K Dhanda, et al.Nature Genetics|April 8, 2014
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutationsPawel Buczkowicz, Christine Hoeman, Patricia Rakopoulos, et al.Nature Communications|September 27, 2019
Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomasAna S Guerreiro Stucklin, Scott Ryall, Kohei Fukuoka, et al.JCO Precision Oncology|September 14, 2020
Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF InhibitionLiana Nobre, Michal Zapotocky, Vijay Ramaswamy, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2017
Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade GliomasAlvaro Lassaletta, Michal Zapotocky, Matthew Mistry, et al.Pageof 3